Real-world skin treatment outcomes in Chinese teens and adults

This is an observational study tracking how upadacitinib works when prescribed by doctors for moderate to severe atopic dermatitis (a chronic inflammatory skin condition causing rash and itching) in real-world settings across China. Researchers will follow approximately 1,000 teenagers and adults for about 12 months to see how well the medication works and whether treatment goals are being met in everyday clinical practice.

While this medication is already approved for treating atopic dermatitis, doctors and researchers want to understand how well it actually works when patients use it in routine care outside of controlled research settings, and whether the treatment goals are being achieved in real-world conditions in China.